These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 15578803)

  • 21. Clinicopathologic and molecular correlations of necrosis in the primary tumor of patients with renal cell carcinoma.
    Lam JS; Shvarts O; Said JW; Pantuck AJ; Seligson DB; Aldridge ME; Bui MH; Liu X; Horvath S; Figlin RA; Belldegrun AS
    Cancer; 2005 Jun; 103(12):2517-25. PubMed ID: 15880379
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of E-cadherin, and CD44s and CD44v6 and its association with prognosis in head and neck cancer.
    Kawano T; Nakamura Y; Yanoma S; Kubota A; Furukawa M; Miyagi Y; Tsukuda M
    Auris Nasus Larynx; 2004 Mar; 31(1):35-41. PubMed ID: 15041052
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CD44 expression in sinonasal melanomas: is loss of isoform expression associated with advanced tumour stage?
    Regauer S; Ott A; Berghold A; Beham A
    J Pathol; 1999 Jan; 187(2):184-90. PubMed ID: 10365093
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of CD44 isoforms in renal cell tumors. Positive correlation to tumor differentiation.
    Terpe HJ; Störkel S; Zimmer U; Anquez V; Fischer C; Pantel K; Günthert U
    Am J Pathol; 1996 Feb; 148(2):453-63. PubMed ID: 8579108
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reduced CD44 standard expression is associated with tumour recurrence and unfavourable outcome in differentiated thyroid carcinoma.
    Böhm JP; Niskanen LK; Pirinen RT; Kiraly K; Kellokoski JK; Moisio KI; Eskelinen MJ; Tulla HE; Hollmen S; Alhava EM; Kosma VM
    J Pathol; 2000 Nov; 192(3):321-7. PubMed ID: 11054715
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prognostic significance of vascular endothelial growth factor expression in clear cell renal cell carcinoma.
    Djordjevic G; Mozetic V; Mozetic DV; Licul V; Ilijas KM; Mustac E; Oguic R; Fuckar Z; Jonjic N
    Pathol Res Pract; 2007; 203(2):99-106. PubMed ID: 17270362
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CD44 expression and its relationship with MMP-9, clinicopathological factors and survival in oral squamous cell carcinoma.
    Kosunen A; Pirinen R; Ropponen K; Pukkila M; Kellokoski J; Virtaniemi J; Sironen R; Juhola M; Kumpulainen E; Johansson R; Nuutinen J; Kosma VM
    Oral Oncol; 2007 Jan; 43(1):51-9. PubMed ID: 16798062
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metallothionein expression in renal cell carcinoma: subcellular localization and prognostic significance.
    Tüzel E; Kirkali Z; Yörükoglu K; Mungan MU; Sade M
    J Urol; 2001 May; 165(5):1710-3. PubMed ID: 11342961
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Location of extrarenal tumor extension does not impact survival of patients with pT3a renal cell carcinoma.
    Margulis V; Tamboli P; Matin SF; Meisner M; Swanson DA; Wood CG
    J Urol; 2007 Nov; 178(5):1878-82. PubMed ID: 17868733
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Expression of standard CD44 in human colorectal carcinoma: association with prognosis.
    Huh JW; Kim HR; Kim YJ; Lee JH; Park YS; Cho SH; Joo JK
    Pathol Int; 2009 Apr; 59(4):241-6. PubMed ID: 19351367
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Morphological subtyping of papillary renal cell carcinoma: clinicopathological characteristics and prognosis.
    Yamashita S; Ioritani N; Oikawa K; Aizawa M; Endoh M; Arai Y
    Int J Urol; 2007 Aug; 14(8):679-83. PubMed ID: 17681054
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prognostic value of renal vein and inferior vena cava involvement in renal cell carcinoma.
    Wagner B; Patard JJ; Méjean A; Bensalah K; Verhoest G; Zigeuner R; Ficarra V; Tostain J; Mulders P; Chautard D; Descotes JL; de la Taille A; Salomon L; Prayer-Galetti T; Cindolo L; Valéri A; Meyer N; Jacqmin D; Lang H
    Eur Urol; 2009 Feb; 55(2):452-9. PubMed ID: 18692951
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Heterogeneous p27(Kip1) expression within primary renal cell cancers, their invasive margins and peritumoral renal parenchyma correlation with pathological and prognostic features.
    Merseburger AS; Serth J; von der Heyde E; Kobierski A; Wegener U; Mengel M; Jonas U; Kuczyk M
    Urol Int; 2007; 79(2):164-9. PubMed ID: 17851288
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognostic factors in a prospective series of papillary renal cell carcinoma.
    Gontero P; Ceratti G; Guglielmetti S; Andorno A; Terrone C; Bonvini D; Faggiano F; Tizzani A; Frea B; Valente G
    BJU Int; 2008 Sep; 102(6):697-702. PubMed ID: 18489525
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Claudin-1 protein expression is a prognostic marker of patient survival in renal cell carcinomas.
    Fritzsche FR; Oelrich B; Johannsen M; Kristiansen I; Moch H; Jung K; Kristiansen G
    Clin Cancer Res; 2008 Nov; 14(21):7035-42. PubMed ID: 18981000
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Significance of macroscopic tumor necrosis as a prognostic indicator for renal cell carcinoma.
    Lee SE; Byun SS; Oh JK; Lee SC; Chang IH; Choe G; Hong SK
    J Urol; 2006 Oct; 176(4 Pt 1):1332-7; discussion 1337-8. PubMed ID: 16952624
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Fatty acid synthase over expression is an indicator of tumor aggressiveness and poor prognosis in renal cell carcinoma.
    Horiguchi A; Asano T; Asano T; Ito K; Sumitomo M; Hayakawa M
    J Urol; 2008 Sep; 180(3):1137-40. PubMed ID: 18639282
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Minichromosome maintenance proteins 2 and 5 expression in muscle-invasive urothelial cancer: a multivariate survival study including proliferation markers and cell cycle regulators.
    Korkolopoulou P; Givalos N; Saetta A; Goudopoulou A; Gakiopoulou H; Thymara I; Thomas-Tsagli E; Patsouris E
    Hum Pathol; 2005 Aug; 36(8):899-907. PubMed ID: 16112007
    [TBL] [Abstract][Full Text] [Related]  

  • 39. CD44 expression is associated with increased survival in node-negative invasive breast carcinoma.
    Diaz LK; Zhou X; Wright ET; Cristofanilli M; Smith T; Yang Y; Sneige N; Sahin A; Gilcrease MZ
    Clin Cancer Res; 2005 May; 11(9):3309-14. PubMed ID: 15867228
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Increased expression of CD44s in conventional renal cell carcinomas with renal vein or vena cava thrombosis. a retrospective evaluation of the expression of CD44s by immunohistochemical analysis in conventional RCC patients and in conventional RCC patients with renal vein or vena cava thrombosis.
    Altinel M; Arpali E; Turhan N; Gonenc F; Yazicioglu A
    Urol Int; 2008; 81(4):452-5. PubMed ID: 19077409
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.